Dabur India Ltd

Profit before exceptional items and tax rose to Rs 726.16 crore from Rs 657.58 crore, including a one-time exceptional charge of Rs 15.05 crore for employee benefits under the new labour codes. The company reported net profit before exceptional items surged 10.1% to Rs 575 crore in Q3 FY26, up from Rs 522 crore a year earlier, while operating profit grew 7.7% to Rs 734 crore during the quarter. Total expenses were at Rs 2,972.83 crore, up 5.19% in the December 2025 quarter from Rs 2,826.20 crore in the year ago period. The India FMCG business reported 6% growth during the quarter, with rural demand outperforming urban markets for the eighth consecutive quarter. Syndicated data showed a 330-basis-point growth gap in favour of rural markets, a trend mirrored in Dabur's internal numbers. Dabur said its total reach expanded by 50,000 outlets during the quarter, taking distribution to over 8.5 million outlets, making it the second most distributed FMCG company in India. Its rural footprint now spans more than 133,000 villages. Category performance remained strong in Q3 FY26, led by a 19.1% surge in the Hair Oils business, which helped Dabur gain 193 basis points in market share, taking its overall share to around 20%'the highest ever. The Foods business grew 14%, while Toothpaste, led by Dabur Red and Meswak, rose around 10%. Juices & Nectars gained 195 basis points in market share, with the 100% juices segment up around 646 basis points, and Air Fresheners touched a 44% share after a 131-basis-point gain. The Skin & Salon business grew 6.6%, while Hajmola reported 7% growth during the quarter. Dabur's international business delivered 11.1% year-on-year growth in Q3 FY26, driven by strong performances across key geographies. The company reported 20.2% growth in Bangladesh, 19.3% in the US, 15.4% in Turkey, and 12.5% in MENA during the quarter. Mohit Malhotra, chief executive officer, Dabur India, said, Dabur delivered a steady quarter, with healthy volume-led growth across our key business verticals and geographies. We have sharpened our competitive edge through stronger innovation and focused brand building, leading to healthy market share gains. As demand conditions improve, the combination of favorable macroeconomic indicators and expectations of supportive policy measures, reinforced by recent GST changes, positions us well for the quarters ahead, and we remain confident of delivering sustainable growth, resilient profitability, and continued shareholder value. Dabur is one of India's leading FMCG companies, specializing in Ayurveda and natural health care, with an extensive distribution network spanning India and key international markets.Powered by Capital Market - Live

Net profit of Dabur India rose 7.20% to Rs 559.97 crore in the quarter ended December 2025 as against Rs 522.38 crore during the previous quarter ended December 2024. Sales rose 6.06% to Rs 3558.65 crore in the quarter ended December 2025 as against Rs 3355.25 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales3558.653355.25 6 OPM %20.6220.32 - PBDT843.35766.22 10 PBT726.16657.58 10 NP559.97522.38 7 Powered by Capital Market - Live

In October 2025, distributors and retailers focused on liquidating higher-priced inventory, and post-trade stabilisation helped improve consumer sentiment across urban and rural markets. Rural demand continued to outperform urban areas during the quarter. Within the domestic business, the Home & Personal Care segment is expected to deliver double-digit growth, driven by strong performance in Hair Oils and Oral Care categories. Key brands likely to lead volume growth include Dabur Amla, Dabur Almond, Dabur Anmol, Dabur Red Toothpaste, and Meswak. Most of the portfolio is expected to outperform category growth, supporting market share gains in several categories. The Healthcare segment is projected to see sequential improvement, supported by nearly 10% growth in Dabur Honey and 15%+ YoY growth in Honitus and Health Juices. Hajmola and the Ethicals portfolio are likely to post mid-single digit growth. While primary sales of Dabur Chyawanprash may remain muted, secondary sales remain positive, with momentum expected to strengthen in January 2026 due to an extended winter. Overall, the Healthcare segment is expected to report low-single digit growth. In Food & Beverages, the Culinary business is expected to achieve double-digit growth. The Beverages portfolio, particularly Nectars & Drinks, may see muted performance due to seasonality, but the premium 'Real Activ' range is performing strongly, with 100% Activ juices and Coconut Water expected to grow 30%+, registering market share gains and reinforcing the brand's premium positioning. On the distribution and sales channels front, organised trade continues to maintain strong growth momentum. E-commerce, including Quick Commerce, is expected to deliver robust double-digit growth, reflecting increasing online penetration in both urban and semi-urban markets. The international business performed well in key geographies such as MENA, Turkey, Namaste, and Bangladesh, supporting near double-digit growth in INR terms. Overall, Dabur India expects consolidated revenue to grow in mid-single digits, with operating profit and net profit projected to outpace revenue growth. The company said that favourable macroeconomic conditions, GST rate revisions, and recent tax reforms are expected to support a sustained recovery in consumer demand and improve revenue trajectory in the coming quarters. Dabur is India's leading FMCG, Ayurvedic and natural health care companies with wide network distribution across world. Shares of Dabur India shed 0.50% to currently trade at Rs 518.60 on the BSE. Powered by Capital Market - Live

Dabur India Ltd is up for a third straight session in a row. The stock is quoting at Rs 506.1, up 2.11% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.76% on the day, quoting at 26136.25. The Sensex is at 85259.33, up 0.69%. Dabur India Ltd has dropped around 1.78% in last one month. Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has dropped around 0.07% in last one month and is currently quoting at 55033.15, up 0.92% on the day. The volume in the stock stood at 14.42 lakh shares today, compared to the daily average of 12.4 lakh shares in last one month. The benchmark January futures contract for the stock is quoting at Rs 509.05, up 2.12% on the day. Dabur India Ltd is down 0.95% in last one year as compared to a 10.08% gain in NIFTY and a 2.59% gain in the Nifty FMCG index.The PE of the stock is 61.72 based on TTM earnings ending September 25.Powered by Capital Market - Live

Dabur India Ltd dropped for a fifth straight session today. The stock is quoting at Rs 487.25, down 0.19% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.36% on the day, quoting at 25948.55. The Sensex is at 84699.55, down 0.4%.Dabur India Ltd has lost around 5.43% in last one month.Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has eased around 0.77% in last one month and is currently quoting at 55132.05, down 0.1% on the day. The volume in the stock stood at 6.34 lakh shares today, compared to the daily average of 12.02 lakh shares in last one month. The benchmark December futures contract for the stock is quoting at Rs 489.95, up 0.01% on the day. Dabur India Ltd tumbled 3.56% in last one year as compared to a 9.74% rally in NIFTY and a 2.73% fall in the Nifty FMCG index.The PE of the stock is 60.83 based on TTM earnings ending September 25.Powered by Capital Market - Live

Dabur India will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live

Dabur India Ltd dropped for a fifth straight session today. The stock is quoting at Rs 496.3, down 1.09% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.5% on the day, quoting at 26028.95. The Sensex is at 85234.87, up 0.49%.Dabur India Ltd has lost around 4.96% in last one month.Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has eased around 1.55% in last one month and is currently quoting at 54619.65, down 0.43% on the day. The volume in the stock stood at 6.68 lakh shares today, compared to the daily average of 18.89 lakh shares in last one month. The benchmark December futures contract for the stock is quoting at Rs 496.35, down 1.38% on the day. Dabur India Ltd tumbled 3.22% in last one year as compared to a 5.09% rally in NIFTY and a 4.37% fall in the Nifty FMCG index.The PE of the stock is 62.53 based on TTM earnings ending September 25.Powered by Capital Market - Live

Dabur India Ltd is up for a third straight session today. The stock is quoting at Rs 528.1, up 1.11% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.3% on the day, quoting at 25952.55. The Sensex is at 84734.14, up 0.32%. Dabur India Ltd has gained around 8.36% in last one month. Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has gained around 2.42% in last one month and is currently quoting at 55529.2, down 0% on the day. The volume in the stock stood at 10.06 lakh shares today, compared to the daily average of 26 lakh shares in last one month. The benchmark November futures contract for the stock is quoting at Rs 527.55, up 0.57% on the day. Dabur India Ltd is up 3.94% in last one year as compared to a 10.28% jump in NIFTY and a 0.46% jump in the Nifty FMCG index.The PE of the stock is 65.02 based on TTM earnings ending September 25.Powered by Capital Market - Live

Revenue from operations was at Rs 3,191.32 crore in the second quarter of FY26, up 5.37% year on year. Profit before tax stood at Rs 573.02 crore in Q2 FY26, up 4.95% as against Rs 545.96 crore posted in Q2 FY25. Dabur India's total expenses were at Rs 2,758.33 crore, up 4.70% in the September 2025 quarter from Rs 2,634.40 crore in the year ago period. Dabur India reported steady growth across major verticals, including health supplements, toothpaste, hair care, skin care, and home care, during the second quarter. The toothpaste segment led the performance with a 14.3% year-on-year growth, driven by strong demand for dabur red paste and the premium brand Meswak. The company's 100% fruit juice portfolio under the real activ brand surged over 45%, while the overall foods portfolio grew by more than 14%. In the personal care segment, shampoo sales rose over 9%, and the hair oils business expanded by more than 5%. The skin & salon portfolio grew around 8%, while home care recorded over 5% growth during the quarter. Dabur also gained market share across several key categories. Real Nectars gained 115 basis points (bps), the 100% Juices portfolio reported a 1,074-bps improvement, hair oils gained 232 bps, chyawanprash expanded by 234 bps, and air fresheners added 127 bps in market share. Dabur's international business delivered a robust 7.7% year-on-year growth in the second quarter, driven by strong performances across key geographies. The company reported over 17% growth in Dubai, while the UK business surged around 48%. In Bangladesh and the US, revenues grew by approximately 16% each, and Turkey posted an impressive 18% growth during the quarter. Dabur said this performance reflects its agility in navigating global challenges while staying true to its Ayurvedic heritage and innovation-led strategy. Dabur India's board has approved the launch of Dabur Ventures, a new investment platform with a capital allocation of up to Rs 500 crore. The initiative will be fully funded through Dabur's balance sheet and will focus on investing in high-potential, new-age digital-first businesses that exhibit strong growth potential. The company said the move aligns with its long-term strategic vision of expanding into emerging consumer categories and strengthening its digital and innovation-led growth ecosystem. Mohit Mathotra, chief executive officer, Dabur lndia, said, Our performance during the quarter stands as a testament to Dabur's enduring resilience and consumer trust. Despite a dynamic economic environment and transitional GST headwinds, we delivered robust topline and bottomline growth, reaffirming our leadership across core categories. Our India business reported market share gains across 95% of the portfolio, a clear testament to our focused brand investments and deep consumer connect. We are entering a new phase of growth, powered by a future-ready strategy and deep consumer trust. We are investing boldly in premiumization, digital transformation, and distribution expansion, three pillars that will define the next chapter of our journey. As macroeconomic indicators turn favorable and GST reforms unlock afford ability, Dabur is uniquely positioned to accelerate inclusive growth and reinforce its leadership across segments. Our approach will be to invest in new-age future forward businesses in the spaces of Personal Care, Health Care, Wellness Foods, Beverages, and Ayurveda. This initiative underscores our commitment to innovation-Led growth, while accelerating our premiumisation journey and opening doors to emerging consumer spaces that define the future of our industry. Meanwhile, the board of directors of Dabur India has approved an interim dividend of 275% for the financial year 2025-26. The dividend amounts to Rs 2.75 per share, translating to a total payout of Rs 487.76 crore, in line with the company's consistent shareholder return policy. Dabur is India's leading FMCG, Ayurvedic and natural health care companies with wide network distribution across world. Shares of Dabur India fell 2.11% to Rs 490.75 on the BSE. Powered by Capital Market - Live

Net profit of Dabur India rose 6.48% to Rs 452.55 crore in the quarter ended September 2025 as against Rs 425.00 crore during the previous quarter ended September 2024. Sales rose 5.37% to Rs 3191.32 crore in the quarter ended September 2025 as against Rs 3028.59 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales3191.323028.59 5 OPM %18.4218.24 - PBDT688.42656.92 5 PBT573.02545.95 5 NP452.55425.00 6 Powered by Capital Market - Live